menu
    • menu

    Company profile for Adrestia Therapeutics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells Many of the most challenging medical problems facing us today, such as cardiovascular disease, dementia and other neurological conditions, cancer and many genetic disorders, are caused by faulty molecular pathways that lead to cellular dysfunction or death. We are searching for novel t...
    Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells Many of the most challenging medical problems facing us today, such as cardiovascular disease, dementia and other neurological conditions, cancer and many genetic disorders, are caused by faulty molecular pathways that lead to cellular dysfunction or death. We are searching for novel therapies that suppress or over-ride these harmful pathways and keep cells healthy. It’s a concept known as synthetic viability. Adrestia is developing therapeutics that work in an entirely new way.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Adrestia Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Moneta Building 280 Babraham Research Campus Babraham, Cambridge CB22 3AT
    Telephone
    Telephone
    01223 804142
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://adrestia.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adrestia Co-Founder Professor Steve Jackson Named Knight Bachelor for Services
    Adrestia Co-Founder Professor Steve Jackson Named Knight Bachelor for Services

    16 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230616268448/en

    BUSINESSWIRE
    16 Jun 2023
    Share Share
    Adrestia Partners with Leading Patient Advocacy Groups to Form Ataxia Consortium
    Adrestia Partners with Leading Patient Advocacy Groups to Form Ataxia Consortium

    08 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230208005076/en

    BUSINESSWIRE
    08 Feb 2023
    Share Share
    Adrestia appoints Head of Chemistry & initiates partnership with Proteros
    Adrestia appoints Head of Chemistry & initiates partnership with Proteros

    25 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221025005119/en

    BUSINESSWIRE
    25 Oct 2022
    Share Share
    Proteros & Adrestia initiate partnership to discover drugs for genetic diseases
    Proteros & Adrestia initiate partnership to discover drugs for genetic diseases

    25 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/25/2540748/0/en/Proteros-and-Adrestia-initiate-multi-target-partnership-to-discover-first-in-class-drugs-for-intractable-genetic-diseases.html

    GLOBENEWSWIRE
    25 Oct 2022
    Share Share
    Adrestia appoints Will Lewis as Chair and appoints new functional leads
    Adrestia appoints Will Lewis as Chair and appoints new functional leads

    29 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220928005044/en

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    Adrestia Appoints Prof. J. Perry, to Build Human Genetics Computational Platform
    Adrestia Appoints Prof. J. Perry, to Build Human Genetics Computational Platform

    18 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220518005013/en

    BUSINESSWIRE
    18 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search